SIMILAR PATTERNS OF AMINO ACIDS FOR 6A5K_A_SAMA805_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1buc | BUTYRYL-COADEHYDROGENASE (Megasphaeraelsdenii) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | GLU A 56ASN A 99LYS A 110CYH A 97LEU A 114 | None | 1.43A | 6a5kA-1bucA:2.3 | 6a5kA-1bucA:22.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 9 | ARG A 159GLY A 160TRP A 161ASN A 241HIS A 242TYR A 283CYH A 306CYH A 308LEU A 317 | NoneSAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) ZN A 4 (-2.2A)SAH A 319 (-3.9A) | 0.89A | 6a5kA-1pegA:23.7 | 6a5kA-1pegA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | ARG A 159GLY A 160TRP A 161HIS A 242TYR A 283CYH A 308 | NoneSAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 (-2.2A) | 1.38A | 6a5kA-1pegA:23.7 | 6a5kA-1pegA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | ARG A 159GLY A 162HIS A 242TYR A 283CYH A 306CYH A 308 | NoneNoneSAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) ZN A 4 (-2.2A) | 1.33A | 6a5kA-1pegA:23.7 | 6a5kA-1pegA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | ARG A 150GLY A 149HIS A 220CYH A 289LEU A 298 | NoneNoneSAM A 304 (-4.9A) ZN A 300 ( 2.3A)SAM A 304 (-4.7A) | 1.50A | 6a5kA-2r3aA:5.7 | 6a5kA-2r3aA:25.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 9 | ARG A 150GLY A 151TRP A 152ASN A 219HIS A 220TYR A 261CYH A 287CYH A 289LEU A 298 | NoneSAM A 304 (-3.5A)NoneSAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) ZN A 300 ( 2.3A)SAM A 304 (-4.7A) | 0.65A | 6a5kA-2r3aA:5.7 | 6a5kA-2r3aA:25.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | ARG A 150GLY A 153HIS A 220TYR A 261CYH A 287CYH A 289LEU A 298 | NoneNoneSAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) ZN A 300 ( 2.3A)SAM A 304 (-4.7A) | 1.44A | 6a5kA-2r3aA:5.7 | 6a5kA-2r3aA:25.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 151TRP A 152HIS A 220TYR A 261CYH A 289 | SAM A 304 (-3.5A)NoneSAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 1.44A | 6a5kA-2r3aA:5.7 | 6a5kA-2r3aA:25.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 7 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957CYH A3959LEU A3968 | SAH A4971 ( 3.7A)SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) ZN A4970 ( 2.3A) ZN A4970 (-2.3A)SAH A4971 ( 4.9A) | 0.48A | 6a5kA-2w5zA:12.3 | 6a5kA-2w5zA:16.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3842HIS A3907TYR A3944CYH A3957CYH A3959 | NoneSAH A4971 (-4.7A)SAH A4971 (-4.9A) ZN A4970 ( 2.3A) ZN A4970 (-2.3A) | 1.14A | 6a5kA-2w5zA:12.3 | 6a5kA-2w5zA:16.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 136TRP A 137ASN A 209HIS A 210CYH A 273 | SAH A 305 (-3.8A)NoneSAH A 305 (-3.4A)None ZN A 304 ( 2.3A) | 1.10A | 6a5kA-3bo5A:24.7 | 6a5kA-3bo5A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 8 | GLY A 136TRP A 137ASN A 209HIS A 210TYR A 248CYH A 273CYH A 275LEU A 284 | SAH A 305 (-3.8A)NoneSAH A 305 (-3.4A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) ZN A 304 ( 2.3A)SAH A 305 (-4.5A) | 0.38A | 6a5kA-3bo5A:24.7 | 6a5kA-3bo5A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 136TRP A 137HIS A 210TYR A 248CYH A 275 | SAH A 305 (-3.8A)NoneNoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 1.40A | 6a5kA-3bo5A:24.7 | 6a5kA-3bo5A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 138HIS A 210TYR A 248CYH A 273CYH A 275LEU A 284 | NoneNoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) ZN A 304 ( 2.3A)SAH A 305 (-4.5A) | 1.13A | 6a5kA-3bo5A:24.7 | 6a5kA-3bo5A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | TRP A 137ASN A 209HIS A 210TYR A 248LYS A 271LEU A 284 | NoneSAH A 305 (-3.4A)NoneSAH A 305 (-4.9A)SAH A 305 ( 4.1A)SAH A 305 (-4.5A) | 1.24A | 6a5kA-3bo5A:24.7 | 6a5kA-3bo5A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.10A | 6a5kA-3n71A:5.4 | 6a5kA-3n71A:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.42A | 6a5kA-3n71A:5.4 | 6a5kA-3n71A:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 8 | ARG A 101GLY A 102TRP A 103ASN A 169HIS A 170CYH A 219CYH A 221LEU A 230 | SO4 A 235 ( 4.0A)SAM A 237 ( 3.7A)NoneSAM A 237 (-3.3A)SAM A 237 (-4.7A) ZN A 232 ( 2.3A) ZN A 232 (-2.3A)SAM A 237 (-4.8A) | 0.87A | 6a5kA-3ooiA:14.7 | 6a5kA-3ooiA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 8 | ARG A 101GLY A 102TRP A 103ASN A 169HIS A 170TYR A 207CYH A 219CYH A 221 | SO4 A 235 ( 4.0A)SAM A 237 ( 3.7A)NoneSAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A) ZN A 232 (-2.3A) | 0.60A | 6a5kA-3ooiA:14.7 | 6a5kA-3ooiA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 6 | ARG A 101GLY A 104HIS A 170TYR A 207CYH A 219CYH A 221 | SO4 A 235 ( 4.0A)NoneSAM A 237 (-4.7A)None ZN A 232 ( 2.3A) ZN A 232 (-2.3A) | 1.32A | 6a5kA-3ooiA:14.7 | 6a5kA-3ooiA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 5 | GLY A 102TRP A 103ASN A 169CYH A 171LEU A 230 | SAM A 237 ( 3.7A)NoneSAM A 237 (-3.3A)NoneSAM A 237 (-4.8A) | 1.38A | 6a5kA-3ooiA:14.7 | 6a5kA-3ooiA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 5 | GLY A 102TRP A 103HIS A 170TYR A 207CYH A 221 | SAM A 237 ( 3.7A)NoneSAM A 237 (-4.7A)None ZN A 232 (-2.3A) | 1.36A | 6a5kA-3ooiA:14.7 | 6a5kA-3ooiA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 7 | GLY A2151TRP A2152ASN A2217HIS A2218TYR A2255CYH A2268CYH A2270 | SAM A 7 (-3.4A)NoneSAM A 7 (-3.9A)NoneNone ZN A 1 ( 2.5A) ZN A 1 (-2.7A) | 0.48A | 6a5kA-3opeA:12.7 | 6a5kA-3opeA:18.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 5 | GLY A2151TRP A2152HIS A2218TYR A2255CYH A2270 | SAM A 7 (-3.4A)NoneNoneNone ZN A 1 (-2.7A) | 1.28A | 6a5kA-3opeA:12.7 | 6a5kA-3opeA:18.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 5 | GLY A2153HIS A2218TYR A2255CYH A2268CYH A2270 | NoneNoneNone ZN A 1 ( 2.5A) ZN A 1 (-2.7A) | 1.08A | 6a5kA-3opeA:12.7 | 6a5kA-3opeA:18.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4au7 | HISTONE-LYSINEN-METHYLTRANSFERASESUV420H2 (Mus musculus) |
PF00856(SET) | 5 | ASN A 182HIS A 183TYR A 217CYH A 229CYH A 231 | SAH A1247 (-3.1A)SAH A1247 (-4.6A)None ZN A1248 ( 2.3A) ZN A1248 ( 2.2A) | 0.34A | 6a5kA-4au7A:5.6 | 6a5kA-4au7A:19.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4duu | PLASMINOGEN (Homo sapiens) |
PF00024(PAN_1)PF00051(Kringle)PF00089(Trypsin) | 5 | GLY A 415TRP A 417HIS A 360CYH A 435CYH A 358 | None | 1.23A | 6a5kA-4duuA:undetectable | 6a5kA-4duuA:21.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 8 | GLY A1561TRP A1562ASN A1628HIS A1629CYH A1678PHE A1679CYH A1680LEU A1689 | 0UM A1804 (-3.5A)None0UM A1804 (-3.3A)None ZN A1803 ( 2.2A)0UM A1804 (-4.4A) ZN A1803 (-2.2A)0UM A1804 (-4.8A) | 0.50A | 6a5kA-4fmuA:15.1 | 6a5kA-4fmuA:20.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mi5 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A 628TRP A 629ASN A 693HIS A 694TYR A 731 | None | 0.75A | 6a5kA-4mi5A:7.3 | 6a5kA-4mi5A:18.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mud | RING OXYDATIONCOMPLEX/PHENYLACETIC ACIDDEGRADATION RELATEDPROTEIN (Sulfolobussolfataricus) |
PF05138(PaaA_PaaC) | 5 | GLY A 63TRP A 64GLU A 141PHE A 28LEU A 120 | None | 1.47A | 6a5kA-4mudA:undetectable | 6a5kA-4mudA:18.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 9 | GLY A 457TRP A 458GLU A 492ASN A 551HIS A 552TYR A 593CYH A 612CYH A 614LEU A 623 | SAH A 801 (-3.6A)SAH A 801 (-4.9A)SAH A 801 ( 3.2A)SAH A 801 (-3.2A)NoneNone ZN A 805 ( 2.4A) ZN A 805 ( 2.4A)None | 0.49A | 6a5kA-4qeoA:38.4 | 6a5kA-4qeoA:40.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 5 | GLY A 457TRP A 458HIS A 552TYR A 593CYH A 614 | SAH A 801 (-3.6A)SAH A 801 (-4.9A)NoneNone ZN A 805 ( 2.4A) | 1.47A | 6a5kA-4qeoA:38.4 | 6a5kA-4qeoA:40.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w2r | ENHANCER OF ZESTE 2POLYCOMB REPRESSIVECOMPLEX 2 SUBUNIT (Anoliscarolinensis) |
no annotation | 5 | GLY A 520TRP A 521ASN A 585HIS A 586TYR A 623 | CJD A 708 (-3.6A)NoneCJD A 708 (-3.5A)NoneNone | 0.59A | 6a5kA-4w2rA:12.9 | 6a5kA-4w2rA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 6 | GLY A5408ASN A5474HIS A5475TYR A5512CYH A5525CYH A5527 | SAH A5602 (-3.6A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) ZN A5601 ( 2.2A) | 0.22A | 6a5kA-4z4pA:13.5 | 6a5kA-4z4pA:15.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cpr | HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1 (Homo sapiens) |
PF00856(SET) | 5 | ASN B 272HIS B 273TYR B 307CYH B 319CYH B 321 | SAM B 402 (-3.1A)SAM B 402 (-4.5A)539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A) | 0.42A | 6a5kA-5cprB:8.3 | 6a5kA-5cprB:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 6 | GLY A4782ASN A4848HIS A4849TYR A4886CYH A4899CYH A4901 | SAH A5002 (-3.5A)SAH A5002 (-2.7A)SAH A5002 (-4.6A)None ZN A5001 ( 2.0A) ZN A5001 (-2.3A) | 0.32A | 6a5kA-5f59A:13.8 | 6a5kA-5f59A:14.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 7 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957CYH A3959LEU A3968 | SAH A4001 (-3.4A)SAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) ZN A4002 (-2.3A)None | 0.55A | 6a5kA-5f6lA:13.9 | 6a5kA-5f6lA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 5 | GLY A3842HIS A3907TYR A3944CYH A3957CYH A3959 | NoneSAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) ZN A4002 (-2.3A) | 1.12A | 6a5kA-5f6lA:13.9 | 6a5kA-5f6lA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jze | RNA-DEPENDENT RNAPOLYMERASE (Thiaforaorthonairovirus) |
PF02338(OTU) | 5 | ARG A 161ASN A 33HIS A 29PHE A 31LEU A 28 | None | 1.44A | 6a5kA-5jzeA:undetectable | 6a5kA-5jzeA:14.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.47A | 6a5kA-5kjmA:6.0 | 6a5kA-5kjmA:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ls6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET)PF11616(EZH2_WD-Binding) | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | 74D A 809 ( 3.9A)None74D A 809 (-3.0A)NoneNone | 0.84A | 6a5kA-5ls6A:12.0 | 6a5kA-5ls6A:24.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 9 | ARG A1073GLY A1074TRP A1075ASN A1141HIS A1142TYR A1179CYH A1191CYH A1193LEU A1202 | NoneSAM A1304 ( 3.2A)NoneSAM A1304 (-2.9A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) ZN A1301 (-2.3A)SAM A1304 ( 4.7A) | 0.73A | 6a5kA-5lsuA:15.2 | 6a5kA-5lsuA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 6 | ARG A1073GLY A1076HIS A1142TYR A1179CYH A1191CYH A1193 | NoneSAM A1304 ( 4.6A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) ZN A1301 (-2.3A) | 1.30A | 6a5kA-5lsuA:15.2 | 6a5kA-5lsuA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1074TRP A1075HIS A1142TYR A1179CYH A1193 | SAM A1304 ( 3.2A)NoneSAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 (-2.3A) | 1.38A | 6a5kA-5lsuA:15.2 | 6a5kA-5lsuA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A1049TRP A1050ASN A1112HIS A1113TYR A1154CYH A1168CYH A1170 | SAM A1505 ( 3.9A)NoneSAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) ZN A1504 (-2.2A) | 0.36A | 6a5kA-5tuyA:6.8 | 6a5kA-5tuyA:22.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A1049TRP A1050ASN A1112HIS A1113TYR A1154CYH A1170 | SAM A1505 ( 3.9A)NoneSAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) | 1.29A | 6a5kA-5tuyA:6.8 | 6a5kA-5tuyA:22.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1051HIS A1113TYR A1154CYH A1168CYH A1170 | NoneSAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) ZN A1504 (-2.2A) | 1.17A | 6a5kA-5tuyA:6.8 | 6a5kA-5tuyA:22.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5udh | E3 UBIQUITIN-PROTEINLIGASE ARIH1 (Homo sapiens) |
PF01485(IBR) | 5 | ASN A 310HIS A 312TYR A 474CYH A 304LEU A 320 | None ZN A 604 (-3.2A)None ZN A 604 (-2.3A)None | 1.06A | 6a5kA-5udhA:undetectable | 6a5kA-5udhA:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A1137TRP A1138ASN A1200HIS A1201TYR A1242CYH A1256CYH A1258 | SAM A3001 (-3.6A)NoneSAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 ( 2.4A) ZN A3005 (-2.3A) | 0.39A | 6a5kA-5vsdA:28.4 | 6a5kA-5vsdA:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1137TRP A1138HIS A1201TYR A1242CYH A1258 | SAM A3001 (-3.6A)NoneSAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 (-2.3A) | 1.35A | 6a5kA-5vsdA:28.4 | 6a5kA-5vsdA:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1139HIS A1201TYR A1242CYH A1256CYH A1258 | NoneSAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 ( 2.4A) ZN A3005 (-2.3A) | 1.17A | 6a5kA-5vsdA:28.4 | 6a5kA-5vsdA:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wg6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,POLYCOMBPROTEIN SUZ12(E.C.2.1.1.43)CHIMERA (Homo sapiens) |
no annotation | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | A9G A9009 ( 4.2A)NoneA9G A9009 (-3.1A)NoneNone | 0.68A | 6a5kA-5wg6A:11.9 | 6a5kA-5wg6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxg | - (-) |
no annotation | 5 | ARG A 14GLU A 130ASN A 205HIS A 206TYR A 239 | SAM A 502 (-4.8A)SAM A 502 (-4.9A)SAM A 502 (-3.1A)None8HR A 501 ( 4.0A) | 1.16A | 6a5kA-5xxgA:6.1 | 6a5kA-5xxgA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxg | - (-) |
no annotation | 5 | GLY A 15ASN A 205HIS A 206TYR A 239CYH A 261 | SAM A 502 ( 3.9A)SAM A 502 (-3.1A)None8HR A 501 ( 4.0A) ZN A 503 (-2.2A) | 0.65A | 6a5kA-5xxgA:6.1 | 6a5kA-5xxgA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxg | - (-) |
no annotation | 5 | GLY A 46HIS A 83CYH A 65CYH A 62LEU A 90 | None ZN A 505 (-3.3A) ZN A 505 (-2.3A) ZN A 505 (-2.3A)None | 1.20A | 6a5kA-5xxgA:6.1 | 6a5kA-5xxgA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 9 | ARG A1155GLY A1156TRP A1157ASN A1223HIS A1224TYR A1261CYH A1273CYH A1275LEU A1284 | NoneSAM A1301 (-3.6A)NoneSAM A1301 (-3.2A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) ZN A1304 (-2.3A)SAM A1301 (-4.6A) | 0.62A | 6a5kA-6cenA:15.0 | 6a5kA-6cenA:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 7 | ARG A1155GLY A1158HIS A1224TYR A1261CYH A1273CYH A1275LEU A1284 | NoneNoneNoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) ZN A1304 (-2.3A)SAM A1301 (-4.6A) | 1.26A | 6a5kA-6cenA:15.0 | 6a5kA-6cenA:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 5 | GLY A1156TRP A1157HIS A1224TYR A1261CYH A1275 | SAM A1301 (-3.6A)NoneNoneSAM A1301 (-4.9A) ZN A1304 (-2.3A) | 1.48A | 6a5kA-6cenA:15.0 | 6a5kA-6cenA:20.85 |